FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples

SILVER SPRING, Md., April 15, 2022 , Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials